However, ERS induced by skeletal muscle exercise can increase the release of muscle factors such as Fibroblast growth factor 21 (FGF21) and IL-6, ultimately reducing liver IR in non-alcoholic fatty liver disease [77,78]. Here, FGF21 is linked to metabolic dysfunction-associated steatotic liver disease.